United States of America based
Cedilla is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics. They work on cancer and other diseases caused by protein dysregulation.
TechnologiesProtein Degraders Startups
Posts Mentioning This Company
Transcription Factor Precision Therapeutic
Cedilla is developing novel small-molecule therapeutics directed to unrecognized allosteric binding sites, providing new ways to target key cancer drivers and treat life threatening diseases.
No services posted yet